For a special limited time:

         Save 30%!

 Get all 3:

           currinBiotech.com
 
            currinTechnology
  
                       and
  
              rick'sResearch

       
  
  for one low price.

                Learn more

You are here: Home » personalized
Print
Profit from the move to personalized medicine


Targeted and personalized therapaies are gaining substantial momentum with big pharma and biotechs. 

Our personalized medicine portfolio was specifically designed to take advantage of the industry-enabling needs of this growing trend.

How's it fared so far?

A snapshot of the stock performance through 6/14/2011 is shown below.






personalized medicine portfolio



Add the power of research in this area to your portfolio...

sign up to receive the free report and you will also receive a report on 3 stocks featured at ASCO aiming to redefine therapies in tough to treat condidtions.




>

Click the button to try CurrinBIOTECH free for 30 Days